entity

Bacteria

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Bacteria: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections
2Hypotheses
3Analyses
0Outgoing
7Incoming

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Autophagy Mechanisms

mechanism · 4866 words

Sulforaphane and Nrf2 Activation for Neuroprotection

therapeutic · 4477 words

blood-brain-barrier

general · 4426 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (7)

SourceRelationTypeStr
Macrophagesassociated_withcell_type0.95
Lc3-Associated Phagocytosistargetsprocess0.85
Antimicrobial Metabolitestargetscompound0.85
Guanylate-Binding Proteinstargetsprotein0.85
Antimicrobial Peptidestargetscompound0.85

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro 0.488 neurodegeneration What are the mechanisms by which gut mic
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis 0.364 neurodegeneration What are the mechanisms by which gut mic

Mentioning Analyses (3)

Scientific analyses that reference this entity

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.675

Do SCFAs directly modulate α-synuclein aggregation in vivo at physiologically re

neurodegeneration | 2026-04-12 | 2 hypotheses Top: 0.537

Do bacterial curli amyloids cross the blood-brain barrier to directly seed α-syn

neurodegeneration | 2026-04-12 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Gene therapy for Parkinson's disease: current landscape, translational challenge [PMID:41837837] Evola V, Parmar MS Expert review of neurotherapeu 2026 0
7-ketocholesterol as a theranostic target: potential applications and future per [PMID:41936993] Lizard G, Sassi K, Mackrill JJ, Ghzaiel Chem Phys Lipids 2026 0
Computational examination of magainin-I-KL mediated disruption of E. coli biofil [PMID:41724836] Vinutha AS, Akshay S, Sree Agash SG, Cha Archives of microbiology 2026 0
The cytoplasmic protein YedX is a potent inhibitor of CsgA amyloid assembly in E [PMID:41581877] Gurnani B, Jain N The Journal of biological chem 2026 0
Biofilm-Associated Amyloid Proteins Linked with the Progression of Neurodegenera [PMID:40141340] Singh AA, Khan F, Song M International journal of molec 2025 0
E.coli-derived CsgA-peptides stimulate cytokine production in microglia and lead [PMID:41476670] Mygind L, Jensen G, Neesgaard V, Krohn K Brain, behavior, & immunity - 2025 0
Neurosurgical gene therapy for central nervous system diseases. [PMID:39191071] Patel RV, Nanda P, Richardson RM Neurotherapeutics : the journa 2024 0
Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC d [PMID:34763085] Tai CH, Lee NC, Chien YH, Byrne BJ, Mura Molecular therapy : the journa 2022 0
[WALANT - Wide Awake Local Anaesthesia No Tourniquet: Complications in elective [PMID:35168268] Wieschollek S, Forster S, Megerle K Handchirurgie, Mikrochirurgie, 2022 0
Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenera [PMID:35571084] Wang C, Zheng C Frontiers in pharmacology 2022 0
Gene therapy restores dopamine transporter expression and ameliorates pathology [PMID:34011628] Ng J, Barral S, De La Fuente Barrigon C, Science translational medicine 2021 0
Current Clinical Applications of In Vivo Gene Therapy with AAVs. [PMID:33309881] Mendell JR, Al-Zaidy SA, Rodino-Klapac L Molecular therapy : the journa 2021 0
Targeting autophagy using small-molecule compounds to improve potential therapy [PMID:34729301] Zhang K, Zhu S, Li J, Jiang T, Feng L, P Acta pharmaceutica Sinica. B 2021 0
Genome-wide screen identifies curli amyloid fibril as a bacterial component prom [PMID:34413194] Wang C, Lau CY, Ma F, Zheng C Proceedings of the National Ac 2021 0
Engineering complex communities by directed evolution. [PMID:33986540] Chang CY, Vila JCC, Bender M, Li R, Mank Nature ecology & evolution 2021 0
Successful Nonoperative Treatment of Osteochondritis Dissecans of the Humeral Ca [PMID:34825100] Tajika T, Kuboi T, Endo F, Hatori Y, Sai Progress in rehabilitation med 2021 0
Graphene bilayers with a twist. [PMID:33208935] ["Andrei E", "MacDonald A"] Nature materials 2020 0
Reconstruction of cell spatial organization from single-cell RNA sequencing data [PMID:32541867] ["Ren X", "Zhong G", "Zhang Q", "Zhang L Cell research 2020 0
Gene therapy for neurodegenerative disorders: advances, insights and prospects. [PMID:32963936] Chen W, Hu Y, Ju D Acta pharmaceutica Sinica. B 2020 0
Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Pr [PMID:32538869] Werner T, Horvath I, Wittung-Stafshede P Journal of Parkinson's disease 2020 0